Furthermore, relationships between CD74 methylation and survival prediction (OS, DSS, DFS, and PFS) were examined by KM curves for all 33 cancer types (Fig. S8), showing that reduced methylation was predictive of longer survival in ACC and BLCA. Here, CD74 is linked to bladder transitional cell carcinoma.